{"id":"https://openalex.org/W1999193296","doi":"https://doi.org/10.1212/wnl.60.1.148-a","title":"No additional benefit of HRT on response to rivastigmine in menopausal women with AD","display_name":"No additional benefit of HRT on response to rivastigmine in menopausal women with AD","alternate_titles":[],"publication_year":2003,"publication_date":"2003-01-14","ids":{"openalex":"https://openalex.org/W1999193296","doi":"https://doi.org/10.1212/wnl.60.1.148-a","mag":"1999193296","pmid":"https://pubmed.ncbi.nlm.nih.gov/12525745"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.60.1.148-a","doi":"https://doi.org/10.1212/wnl.60.1.148-a","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.60.1.148-a","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1999193296"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002320068","display_name":"Anne\u2010Sophie Rigaud","orcid":"https://orcid.org/0000-0002-6827-4417","observed_orcids":["https://orcid.org/0000-0002-6827-4417"]},"institutions":[{"id":"https://openalex.org/I4210106537","display_name":"H\u00f4pital Broca","ror":"https://ror.org/01m11mf96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210106537","https://openalex.org/I4210124464"]},{"id":"https://openalex.org/I4210112060","display_name":"H\u00f4pital Gui de Chauliac","ror":"https://ror.org/02w35z347","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210093292","https://openalex.org/I4210112060"]},{"id":"https://openalex.org/I4210138343","display_name":"H\u00f4pital Purpan","ror":"https://ror.org/03vcx3f97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210138343"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A.S. Rigaud","raw_affiliation_strings":["From the Department of Geriatrics (Dr. Rigaud), Broca Hospital, Paris; Department of Gynecology (Dr. Andre\u0301), Strasbourg; Department of Neurology (Dr. Vellas), Gui de Chauliac University Hospital, Montpellier; Geriatric Clinic (Dr. Touchon), Purpan University Hospital, Toulouse; and Novartis Pharma S.A.S. (Dr. Pere), Rueil-Malmaison, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Geriatrics (Dr. Rigaud), Broca Hospital, Paris; Department of Gynecology (Dr. Andre\u0301), Strasbourg; Department of Neurology (Dr. Vellas), Gui de Chauliac University Hospital, Montpellier; Geriatric Clinic (Dr. Touchon), Purpan University Hospital, Toulouse; and Novartis Pharma S.A.S. (Dr. Pere), Rueil-Malmaison, France","institution_ids":["https://openalex.org/I4210106537","https://openalex.org/I4210112060","https://openalex.org/I4210138343"]}]},{"author_position":"middle","author":{"id":null,"display_name":"G. Andre\u0301","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106537","display_name":"H\u00f4pital Broca","ror":"https://ror.org/01m11mf96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210106537","https://openalex.org/I4210124464"]},{"id":"https://openalex.org/I4210112060","display_name":"H\u00f4pital Gui de Chauliac","ror":"https://ror.org/02w35z347","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210093292","https://openalex.org/I4210112060"]},{"id":"https://openalex.org/I4210138343","display_name":"H\u00f4pital Purpan","ror":"https://ror.org/03vcx3f97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210138343"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G. Andre\u0301","raw_affiliation_strings":["From the Department of Geriatrics (Dr. Rigaud), Broca Hospital, Paris; Department of Gynecology (Dr. Andre\u0301), Strasbourg; Department of Neurology (Dr. Vellas), Gui de Chauliac University Hospital, Montpellier; Geriatric Clinic (Dr. Touchon), Purpan University Hospital, Toulouse; and Novartis Pharma S.A.S. (Dr. Pere), Rueil-Malmaison, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Geriatrics (Dr. Rigaud), Broca Hospital, Paris; Department of Gynecology (Dr. Andre\u0301), Strasbourg; Department of Neurology (Dr. Vellas), Gui de Chauliac University Hospital, Montpellier; Geriatric Clinic (Dr. Touchon), Purpan University Hospital, Toulouse; and Novartis Pharma S.A.S. (Dr. Pere), Rueil-Malmaison, France","institution_ids":["https://openalex.org/I4210106537","https://openalex.org/I4210112060","https://openalex.org/I4210138343"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049484291","display_name":"Bruno J. Vellas","orcid":"https://orcid.org/0000-0002-7678-5065","observed_orcids":["https://orcid.org/0000-0002-7678-5065","https://orcid.org/0009-0004-5560-1898"]},"institutions":[{"id":"https://openalex.org/I4210106537","display_name":"H\u00f4pital Broca","ror":"https://ror.org/01m11mf96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210106537","https://openalex.org/I4210124464"]},{"id":"https://openalex.org/I4210112060","display_name":"H\u00f4pital Gui de Chauliac","ror":"https://ror.org/02w35z347","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210093292","https://openalex.org/I4210112060"]},{"id":"https://openalex.org/I4210138343","display_name":"H\u00f4pital Purpan","ror":"https://ror.org/03vcx3f97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210138343"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"B. Vellas","raw_affiliation_strings":["From the Department of Geriatrics (Dr. Rigaud), Broca Hospital, Paris; Department of Gynecology (Dr. Andre\u0301), Strasbourg; Department of Neurology (Dr. Vellas), Gui de Chauliac University Hospital, Montpellier; Geriatric Clinic (Dr. Touchon), Purpan University Hospital, Toulouse; and Novartis Pharma S.A.S. (Dr. Pere), Rueil-Malmaison, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Geriatrics (Dr. Rigaud), Broca Hospital, Paris; Department of Gynecology (Dr. Andre\u0301), Strasbourg; Department of Neurology (Dr. Vellas), Gui de Chauliac University Hospital, Montpellier; Geriatric Clinic (Dr. Touchon), Purpan University Hospital, Toulouse; and Novartis Pharma S.A.S. (Dr. Pere), Rueil-Malmaison, France","institution_ids":["https://openalex.org/I4210106537","https://openalex.org/I4210112060","https://openalex.org/I4210138343"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107835074","display_name":"Jacques Touchon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106537","display_name":"H\u00f4pital Broca","ror":"https://ror.org/01m11mf96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210106537","https://openalex.org/I4210124464"]},{"id":"https://openalex.org/I4210112060","display_name":"H\u00f4pital Gui de Chauliac","ror":"https://ror.org/02w35z347","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210093292","https://openalex.org/I4210112060"]},{"id":"https://openalex.org/I4210138343","display_name":"H\u00f4pital Purpan","ror":"https://ror.org/03vcx3f97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210138343"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Touchon","raw_affiliation_strings":["From the Department of Geriatrics (Dr. Rigaud), Broca Hospital, Paris; Department of Gynecology (Dr. Andre\u0301), Strasbourg; Department of Neurology (Dr. Vellas), Gui de Chauliac University Hospital, Montpellier; Geriatric Clinic (Dr. Touchon), Purpan University Hospital, Toulouse; and Novartis Pharma S.A.S. (Dr. Pere), Rueil-Malmaison, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Geriatrics (Dr. Rigaud), Broca Hospital, Paris; Department of Gynecology (Dr. Andre\u0301), Strasbourg; Department of Neurology (Dr. Vellas), Gui de Chauliac University Hospital, Montpellier; Geriatric Clinic (Dr. Touchon), Purpan University Hospital, Toulouse; and Novartis Pharma S.A.S. (Dr. Pere), Rueil-Malmaison, France","institution_ids":["https://openalex.org/I4210106537","https://openalex.org/I4210112060","https://openalex.org/I4210138343"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103410054","display_name":"J.-J. P\u00e9r\u00e9","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106537","display_name":"H\u00f4pital Broca","ror":"https://ror.org/01m11mf96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210106537","https://openalex.org/I4210124464"]},{"id":"https://openalex.org/I4210112060","display_name":"H\u00f4pital Gui de Chauliac","ror":"https://ror.org/02w35z347","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210093292","https://openalex.org/I4210112060"]},{"id":"https://openalex.org/I4210138343","display_name":"H\u00f4pital Purpan","ror":"https://ror.org/03vcx3f97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210138343"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J.J. Pere","raw_affiliation_strings":["From the Department of Geriatrics (Dr. Rigaud), Broca Hospital, Paris; Department of Gynecology (Dr. Andre\u0301), Strasbourg; Department of Neurology (Dr. Vellas), Gui de Chauliac University Hospital, Montpellier; Geriatric Clinic (Dr. Touchon), Purpan University Hospital, Toulouse; and Novartis Pharma S.A.S. (Dr. Pere), Rueil-Malmaison, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Geriatrics (Dr. Rigaud), Broca Hospital, Paris; Department of Gynecology (Dr. Andre\u0301), Strasbourg; Department of Neurology (Dr. Vellas), Gui de Chauliac University Hospital, Montpellier; Geriatric Clinic (Dr. Touchon), Purpan University Hospital, Toulouse; and Novartis Pharma S.A.S. (Dr. Pere), Rueil-Malmaison, France","institution_ids":["https://openalex.org/I4210106537","https://openalex.org/I4210112060","https://openalex.org/I4210138343"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.7931,"has_fulltext":false,"cited_by_count":39,"citation_normalized_percentile":{"value":0.85246503,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"60","issue":"1","first_page":"148","last_page":"149"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10694","display_name":"Menopause: Health Impacts and Treatments","score":0.5059000253677368,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10694","display_name":"Menopause: Health Impacts and Treatments","score":0.5059000253677368,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.3319999873638153,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.1273999959230423,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hormone-replacement-therapy","display_name":"hormone replacement therapy","score":0.996999979019165},{"id":"https://openalex.org/keywords/rivastigmine","display_name":"rivastigmine","score":0.9829999804496765},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9330000281333923},{"id":"https://openalex.org/keywords/menopausal-women","display_name":"menopausal women","score":0.9120000004768372},{"id":"https://openalex.org/keywords/estrogen","display_name":"estrogen","score":0.6290000081062317},{"id":"https://openalex.org/keywords/cholinesterase-inhibitors","display_name":"cholinesterase inhibitors","score":0.9480000138282776},{"id":"https://openalex.org/keywords/cognitive-function","display_name":"cognitive function","score":0.4729999899864197},{"id":"https://openalex.org/keywords/mini-mental-state-examination","display_name":"Mini-Mental State Examination","score":0.6840000152587891},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.37599998712539673}],"concepts":[{"id":"https://openalex.org/C2776332859","wikidata":"https://www.wikidata.org/wiki/Q411887","display_name":"Rivastigmine","level":5,"score":0.9300580024719238},{"id":"https://openalex.org/C2779046751","wikidata":"https://www.wikidata.org/wiki/Q421076","display_name":"Tacrine","level":4,"score":0.8507288694381714},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7939953804016113},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6468271613121033},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.49829792976379395},{"id":"https://openalex.org/C2778562196","wikidata":"https://www.wikidata.org/wiki/Q177708","display_name":"Menopause","level":2,"score":0.4783194363117218},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45013725757598877},{"id":"https://openalex.org/C2777164284","wikidata":"https://www.wikidata.org/wiki/Q277954","display_name":"Estrogen","level":2,"score":0.4150984287261963},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.32722389698028564},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.2995472550392151},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.09617972373962402},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.08539414405822754},{"id":"https://openalex.org/C2780904820","wikidata":"https://www.wikidata.org/wiki/Q415081","display_name":"Donepezil","level":4,"score":0.08208483457565308},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C2778816929","wikidata":"https://www.wikidata.org/wiki/Q22676679","display_name":"Acetylcholinesterase","level":3,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068836","descriptor_name":"Rivastigmine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000203","descriptor_name":"Activities of Daily Living","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000279","descriptor_name":"Administration, Cutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002219","descriptor_name":"Carbamates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004958","descriptor_name":"Estradiol","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005602","descriptor_name":"France","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008593","descriptor_name":"Menopause","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D009483","descriptor_name":"Neuropsychological Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011374","descriptor_name":"Progesterone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020249","descriptor_name":"Hormone Replacement Therapy","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D048448","descriptor_name":"Phenylcarbamates","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1212/wnl.60.1.148-a","doi":"https://doi.org/10.1212/wnl.60.1.148-a","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.60.1.148-a","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},{"id":"pmid:12525745","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12525745","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":6,"referenced_works":["https://openalex.org/W8541533","https://openalex.org/W1975829688","https://openalex.org/W2005994343","https://openalex.org/W2128007559","https://openalex.org/W2133910658","https://openalex.org/W3216169949"],"related_works":["https://openalex.org/W2415843930","https://openalex.org/W4211022469","https://openalex.org/W2005056819","https://openalex.org/W2076676029","https://openalex.org/W2070059663","https://openalex.org/W2119619136","https://openalex.org/W2023649754","https://openalex.org/W2041523804","https://openalex.org/W2012276965","https://openalex.org/W2044358931"],"abstract_inverted_index":{"Rivastigmine":[0],"is":[1],"an":[2,153],"approved":[3],"cholinesterase":[4],"inhibitor":[5],"with":[6,59],"proven":[7],"efficacy":[8],"on":[9],"cognitive":[10],"and":[11,63,68,73,76,78,83,92,110],"functional":[12],"deficits":[13],"in":[14,126],"mild":[15],"to":[16],"moderately":[17],"severe":[18],"AD.1":[19],"The":[20],"possibility":[21],"that":[22],"estrogen":[23],"might":[24],"enhance":[25],"effects":[26],"of":[27,37,42,71,156],"cholinergic":[28],"therapy":[29,103],"was":[30],"previously":[31],"suggested":[32],"from":[33,47,123],"post":[34],"hoc":[35],"analyses":[36],"a":[38,84],"30-week,":[39],"multicenter":[40],"trial":[41],"tacrine,2":[43],"but":[44],"no":[45],"results":[46],"randomized,":[48],"placebo-controlled":[49,130],"studies":[50],"are":[51],"available":[52],"so":[53],"far.6\n\nWe":[54],"studied":[55],"117":[56],"menopausal":[57],"women":[58],"AD":[60],"(":[61],"Diagnostic":[62],"Statistical":[64],"Manual,":[65],"4th":[66],"ed.":[67],"National":[69],"Institute":[70],"Neurological":[72],"Communicative":[74],"Diseases":[75],"Stroke\u2013AD":[77],"Related":[79],"Disorders":[80],"Association":[81],"criteria)":[82],"Mini-Mental":[85],"State":[86],"Examination":[87],"(MMSE)":[88],"score":[89],"between":[90],"10":[91,108],"26":[93],"(both":[94],"inclusive).":[95],"Patients":[96],"should":[97],"not":[98],"have":[99],"received":[100,142],"hormone":[101],"replacement":[102],"(HRT)":[104],"for":[105,117],"the":[106,135],"previous":[107,111],"years":[109],"antidementia":[112],"treatment":[113],"had":[114],"been":[115],"interrupted":[116],"at":[118],"least":[119],"3":[120],"months.\n\nSeventeen":[121],"centers":[122],"France":[124],"participated":[125],"this":[127],"28-week,":[128],"double-blind,":[129],"study":[131],"after":[132,152],"approval":[133],"by":[134],"ethics":[136],"committee":[137],"(Cochin":[138],"Hospital,":[139],"Paris).\n\nAll":[140],"patients":[141],"rivastigmine":[143],"(Exelon":[144],"et":[145],"Estraderm,":[146],"Novartis":[147],"Pharma":[148],"AG,":[149],"Stein,":[150],"Switzerland);":[151],"initial":[154],"dosage":[155],"1.5":[157],"mg":[158],"twice":[159],"\u2026":[160]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1999193296","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
